Robert C. Young

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Brent C. Behrens, Thomas C. Hamilton, Hidetaka Masuda et al. · PubMed · 1987 · 500 citations

Chemoprevention Strategy, Oncogenic Agent, Medicine +12

Fungemia with Compromised Host Resistance

Robert C. Young · Annals of Internal Medicine · 1974 · 275 citations

Disease Resistance, Diagnostic Mycology, Host Factor +13

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.

Thomas C. Hamilton, Robert C. Young, Robert F. Ozols · PubMed · 1984 · 167 citations

Gynecological Surgery, Medicine, Gynecology +8

Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice.

Thomas C. Hamilton, Robert C. Young, Karen G. Louie et al. · PubMed · 1984 · 156 citations

Pathology, Gynecology, Massive Ascites +17

Invasive aspergillosis. Absence of detectable antibody response.

Robert C. Young, Johne . Bennett · PubMed · 1971 · 155 citations

Invasive Aspergillosis, Pathogenesis, Pathology +3